Science | Nature | Cell | View More
Natural Products
Daphnetin
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Daphnetin
Price: $40 / 20mg
CAS No.: 486-35-1
Catalog No.: CFN99952
Molecular Formula: C9H6O4
Molecular Weight: 178.14 g/mol
Purity: >=98%
Type of Compound: Coumarins
Physical Desc.: Powder
Source: The herbs of Daphne Korean Nakai
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download: COA    MSDS    SDF    Manual
Similar structural: Comparison (Web)  (SDF)
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / $7.0 / In-stock
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • Instituto de Investigaciones Ag... (Chile)
  • Universiti Putra Malaysia(UPM) (Malaysia)
  • University of Hull (United Kingdom)
  • University of Cincinnati (USA)
  • Heinrich-Heine-University Düss... (Germany)
  • Monash University (Australia)
  • Aveiro University (Portugal)
  • University of East Anglia (United Kingdom)
  • Charles Sturt University (Denmark)
  • Calcutta University (India)
  • University of Padjajaran (Indonesia)
  • More...
Package
Featured Products
Rosavin

Catalog No: CFN99179
CAS No: 84954-92-7
Price: $68/20mg
Irisflorentin

Catalog No: CFN99788
CAS No: 41743-73-1
Price: $40/20mg
Astragaloside IV

Catalog No: CFN99171
CAS No: 84687-43-4
Price: $30/20mg
Alisol A

Catalog No: CFN92542
CAS No: 19885-10-0
Price: $80/20mg
Syringaresinol-di-O-glucoside

Catalog No: CFN90458
CAS No: 66791-77-3
Price: $138/20mg
Hispidulin

Catalog No: CFN99491
CAS No: 1447-88-7
Price: $218/20mg
Vicenin -1

Catalog No: CFN92030
CAS No: 35927-38-9
Price: $268/20mg
Momordicoside P

Catalog No: CFN92308
CAS No: 1011726-62-7
Price: $ / mg
Juglanin

Catalog No: CFN96238
CAS No: 5041-67-8
Price: $318/5mg
Myricitrin

Catalog No: CFN99840
CAS No: 17912-87-7
Price: $40/20mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Daphnetin is a dihydroxycoumarin that is being used in China for the treatment of coagulation disorders, is a protein kinase inhibitor, inhibits EGFR, PKA and PKC with IC50 of 7.67 μM, 9.33 μM and 25.01 μM, respectively, also known to exhibit antimalarial, anti-rheumatoid arthritis, anti-proliferative, anti-inflammatory and anti-oxidant activities. it is also a chelator and an antioxidant. Daphnetin can enhance immunological functions of B lymphocytes, the expression of IL-12 in B lymphocytes can be up-regulated by daphnetin through natural immunity approach.
Targets: NF-kB | TNF-α | Bcl-2/Bax | Calcium Channel | IL Receptor | p38MAPK | ERK | P-gp | cAMP | PKA | PKC | EGFR
In vitro:
Eur J Pharmacol. 2011 Oct 1;668(1-2):35-41.
Differential effects of esculetin and daphnetin on in vitro cell proliferation and in vivo estrogenicity.[Pubmed: 21741969]
Esculetin (6,7-dihydroxycoumarin) and Daphnetin (7,8-dihydroxycoumarin) are secondary metabolites of plants used in folk medicine. These compounds have showed great antiproliferative activity in several tumor cell lines and have been proposed as potential anticancer agents. However, the estrogenic potential of these two compounds has to date not been reported.
METHODS AND RESULTS:
The present study compared esculetin and Daphnetin on the inhibition of cell proliferation and cell cycle progression of the MCF-7 estrogen-responsive human carcinoma cell line. In vivo and in vitro estrogenic activity for both compounds was also evaluated. Esculetin inhibited cell proliferation after 72 h exposure (IC50=193 ± 6.6 μM), while Daphnetin evidenced inhibiting effects starting at 24-h exposure (72 h, IC50=73 ± 4.1 μM). Both effects showed changes in cyclin D1 gene expression. In non-estrogenic conditions (E-screening assay), esculetin produced biphasic response on proliferation of the MCF-7 cells; at 10(-8)-10(-6)M, concentrations induced proliferative effects as EC50=4.07 × 10(-9)M (E(2)=2.91 × 10(-12)M); at higher concentrations (10(-5)-10(-4)M), cell proliferation was inhibited. Relative proliferative effect at E(2) was 52% (E(2)=100), relative proliferative potency was 0.072 (E(2)=100). Additionally, esculetin tested in vivo showed estrogenic effects at 50-100mg/kg doses; relative uterotrophic effect at E(2) was 37%, with relative uterotrophic potency registered at 0.003. In contrast, Daphnetin did not induce estrogenic effects in vitro or with in vivo models. The low estrogenic activity of esculetin could prove useful in postmenopausal therapy but not as a safe antitumor agent in estrogen-dependent tumors.
CONCLUSIONS:
Daphnetin-based antiproliferative selectivity with MCF-7 cells showed that Daphnetin is a promising antitumoral agent also acting on estrogen dependent tumors.
Am J Trop Med Hyg. 1992 Jan;46(1):15-20.
Daphnetin: a novel antimalarial agent with in vitro and in vivo activity.[Pubmed: 1311154]
Daphnetin is a dihydroxycoumarin that is being used in China for the treatment of coagulation disorders. It is also a chelator and an antioxidant. In vitro, Daphnetin causes a 50% inhibition (IC50) of 3H-hypoxanthine incorporation by Plasmodium falciparum at concentrations between 25 and 40 microM. Several related compounds, such as scopoletin, 2, 3-dihydroxybenzoic acid and 3, 4-dihydroxybenzoic acid show no inhibitory activity. The antimalarial activity of Daphnetin is inhibited by the addition of iron. Daphnetin does not appear to be an oxidant drug, since it does not spontaneously generate superoxide in vitro. However, it does alkylate bovine serum albumin when incubated in the presence of iron. In vivo, Daphnetin significantly prolongs survival of P. yoelli-infected mice.
Free Radic Biol Med . 2017 May;106:38-52.
Daphnetin-mediated Nrf2 antioxidant signaling pathways ameliorate tert-butyl hydroperoxide (t-BHP)-induced mitochondrial dysfunction and cell death[Pubmed: 28188924]
Abstract Daphnetin (Daph), a natural coumarin derivative isolated from plants of the Genus Daphne, possesses abundant biological activities, such as anti-inflammatory, antioxidant and anticancer properties. In the present study, we focused on investigating the protective effect of Daph against tert-butyl hydroperoxide (t-BHP)-induced oxidative damage, mitochondrial dysfunction and the involvement of underlying molecular mechanisms. Our findings indicated that Daph effectively inhibited t-BHP-stimulated cytotoxicity, cell apoptosis, and mitochondrial dysfunction, which are associated with suppressed reactive oxygen species (ROS) generation, decreased malondialdehyde (MDA) formation, increased superoxide dismutase (SOD) levels and glutathione (GSH)/GSSG (oxidized GSH) ratio. Further investigation indicated that Daph significantly suppressed cytochrome c release and NLRP3 inflammasome activation and modulated apoptosis-related protein Bcl-2, Bax, and caspase-3 expression. Moreover, Daph dramatically induced the expression of the glutamate-cysteine ligase modifier (GCLM) subunit and the glutamate-cysteine ligase catalytic (GCLC) subunit, heme oxygenase-1 (HO-1), and NAD (P) H: quinone oxidoreductase (NQO1), which is largely dependent on upregulating the nuclear factor-erythroid 2-related factor 2 (Nrf2) nuclear translocation, reducing the Keap1 protein expression, and strengthening the antioxidant response element (ARE) promoter activity. Additionally, Daph remarkably activated a c-Jun NH2-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) phosphorylation, but ERK and JNK inhibitor pretreatment exhibited an evident decrease of the level of Daph-enhanced Nrf2 nuclear translocation. Furthermore, Daph exposure suppressed t-BHP-induced cytotoxicity and ROS overproduction, which are mostly blocked in Nrf2 knockout RAW 264.7 cells and peritoneal macrophages. Accordingly, Daph exhibited protective roles against t-BHP-triggered oxidative damage and mitochondrial dysfunction by the upregulation of Nrf2 antioxidant signaling pathways, which may be involved in the activation of JNK and ERK. Keywords: Daphnetin; Mitochondrial dysfunction; Nrf2; Oxidative damage; ROS.
In vivo:
J Agric Food Chem. 2014 Dec 24;62(51):12315-25.
Anti-inflammatory and protective properties of daphnetin in endotoxin-induced lung injury.[Pubmed: 25419854]
Uncontrolled inflammatory responses cause tissue injury and severe immunopathology. Pharmacological interference of intracellular pro-inflammatory signaling may confer a therapeutic benefit under these conditions. Daphnetin, a natural coumarin derivative, has been used to treat inflammatory diseases including bronchitis. However, the protective effect of Daphnetin in inflammatory airway disorders has yet to be determined, and the molecular basis for its anti-inflammatory properties is unknown.
METHODS AND RESULTS:
This paper shows that Daphnetin treatment conferred substantial protection from endotoxin-induced acute lung injury (ALI), in parallel with reductions in the production of inflammatory mediators, symptoms of airway response, and infiltration of inflammatory cells. Further studies indicate that activation of macrophage and human alveolar epithelial cells in response to lipopolysaccharide (LPS) was remarkably suppressed by Daphnetin, which was related to the down-regulation of NF-κB-dependent signaling events. Importantly, this study demonstrates that TNF-α-induced protein 3 (TNFAIP3), also known as A20, was significantly induced by Daphnetin, which appeared to be largely responsible for the down-regulation of NF-κB activity through modulation of nondegradative TRAF6 ubiquitination. Accordingly, the deletion of TNFAIP3 in primary macrophages reversed Daphnetin-elicited inhibition of immune response, and the beneficial effect of Daphnetin in the pathogenesis of ALI was, partially at least, abrogated by TNFAIP3 knockdown.
CONCLUSIONS:
These findings demonstrate the anti-inflammatory and protective functions of Daphnetin in endotoxin-induced lung inflammation and injury and also reveal the key mechanism underlying its action in vitro as well as in vivo.
Daphnetin Description
Source: The herbs of Daphne Korean Nakai
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Dipsacussaponin C

Catalog No: CFN95353
CAS No: 152406-43-4
Price: $318/5mg
Methyl lucidenate A

Catalog No: CFN95583
CAS No: 105742-79-8
Price: $318/5mg
Maingayone

Catalog No: CFN95479
CAS No: 271585-66-1
Price: $318/10mg
8,8''-Bibaicalein

Catalog No: CFN95007
CAS No: 135309-02-3
Price: $318/5mg
Yuanhuanin

Catalog No: CFN95127
CAS No: 83133-14-6
Price: $318/5mg
Spinacetin

Catalog No: CFN95194
CAS No: 3153-83-1
Price: $318/5mg
3-Hydroxy-4',5-dimethoxystilbene

Catalog No: CFN95199
CAS No: 58436-29-6
Price: $318/10mg
4-Keto-laurifoline

Catalog No: CFN95594
CAS No: N/A
Price: $318/10mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 5.6136 mL 28.0678 mL 56.1356 mL 112.2712 mL 140.3391 mL
5 mM 1.1227 mL 5.6136 mL 11.2271 mL 22.4542 mL 28.0678 mL
10 mM 0.5614 mL 2.8068 mL 5.6136 mL 11.2271 mL 14.0339 mL
50 mM 0.1123 mL 0.5614 mL 1.1227 mL 2.2454 mL 2.8068 mL
100 mM 0.0561 mL 0.2807 mL 0.5614 mL 1.1227 mL 1.4034 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Protocol
Kinase Assay:
Int J Biol Macromol. 2015 Mar;74:185-94.
Groove binding interaction between daphnetin and calf thymus DNA.[Pubmed: 25541356]
The binding characteristics of Daphnetin with calf thymus DNA (ctDNA) were investigated by multispectroscopic and chemometric approaches coupled with DNA viscosity measurements, melting studies and molecular docking technique.
METHODS AND RESULTS:
The expanded UV-vis spectral data matrix was processed by multivariate curve resolution-alternating least-squares method to obtain the concentration profiles of the components (Daphnetin, ctDNA and Daphnetin-ctDNA complex) to quantitatively monitor the Daphnetin-ctDNA interaction. The groove mode of Daphnetin binding to ctDNA was concluded by little change in melting temperature, viscosity of ctDNA and iodide quenching effect as well as increase in single-stranded DNA quenching effect. Moreover, the quantitative data for the competitive binding between Daphnetin and Hoechst 33258 for ctDNA obtained by resolving the three-way synchronous fluorescence spectra data using parallel factor analysis modeling further supported the groove binding. The molecular docking visualized the results of the Fourier transform infrared analysis that the adenine and thymine bases in the minor groove of ctDNA were the main binding sites for Daphnetin, and the circular dichroism spectra showed that the groove binding of Daphnetin to ctDNA led to the conformational change in ctDNA from B-form to A-form.
CONCLUSIONS:
This study revealed the interaction mechanism of Daphnetin with ctDNA.
Biochem Pharmacol. 2004 May 1;67(9):1779-88.
Daphnetin induced differentiation of human renal carcinoma cells and its mediation by p38 mitogen-activated protein kinase.[Pubmed: 15081877 ]
Daphnetin has been shown to be a potent in vitro anti-proliferative agent to the human renal cell carcinoma (RCC) cell line, A-498.
METHODS AND RESULTS:
In the present study, we investigated its effects on mitogen-activated protein kinase (MAPK) signalling along with cell cycle events and cellular differentiation. Daphnetin-activated p38, however, higher concentrations were required to inhibit ERK1/ERK2. In addition, it did not activate SAPK or induce apoptosis, but instead inhibited S phase cell cycle transition of A-498 cells at low concentrations and time of exposure. In addition, a late G(1), early S phase inhibition was observed at higher concentrations and time of exposure, indicating that the mechanism of Daphnetin-induced differentiation was concentration dependent. Increased expression of the epithelial differentiation markers cytokeratins 8 and 18, correlated with increasing concentrations of Daphnetin, while pre-treatment with a specific p38-inhibitor, served to limit this effect. There was no evidence that P-glycoprotein (P-gp) mediated multi-drug resistance (MDR) played a role in the anti-proliferative activity of Daphnetin.
CONCLUSIONS:
Consequently, we concluded that p38 MAP kinase is intrinsically involved in mediating the effect of Daphnetin in A-498 cells, suggesting that this drug may act by promotion of cellular maturation, and consequently may represent a novel low toxic approach for the treatment of poorly differentiated RCCs.
Cell Research:
Molecules. 2014 Sep 15;19(9):14542-55.
Neuroprotective effects of daphnetin against NMDA receptor-mediated excitotoxicity.[Pubmed: 25225718]
The accumulation of glutamate can excessively activate the N-methyl-d-aspartate (NMDA) receptors and cause excitotoxicity. Daphnetin (Dap), a coumarin derivative, is a protein kinase inhibitor that exhibits antioxidant and neuroprotective properties. However, little is known about the neuroprotective effects of Dap on glutamate-induced excitotoxicity.
METHODS AND RESULTS:
We evaluated the neuroprotective activities in the primary cultured cortical neurons against NMDA-induced excitotoxicity. Pretreatment with Dap significantly prevented NMDA-induced neuronal cell loss. Dap significantly inhibited the neuronal apoptosis by regulating balance of Bcl-2 and Bax expression. Furthermore, pretreatment of Dap reversed the up-regulation of NR2B-containing NMDA receptors and inhibited the intracellular Ca2+ overload induced by NMDA exposure. In addition, Dap prevented cerebral ischemic injury in mice induced via a 2 h middle cerebral artery occlusion and a 24 h reperfusion in vivo.
CONCLUSIONS:
The findings suggest that Dap prevents the excitotoxicity through inhibiting the NR2B-containing NMDA receptors and the subsequent calcium overload in cultured cortical neurons.
Animal Research:
J Ethnopharmacol. 2008 Nov 20;120(2):259-63.
Therapeutic effects of daphnetin on adjuvant-induced arthritic rats.[Pubmed: 18835428 ]
Daphnetin was regarded as the mark compound for quality control of Zushima-Pian, a traditional Chinese medicine tablet for treating rheumatoid arthritis (RA). However, no in vivo study on the therapeutic effects of Daphnetin for RA has been reported.
METHODS AND RESULTS:
The adjuvant arthritic (AA) rat model was developed to evaluate the anti-arthritic effects of Daphnetin. After immunized with Freund's complete adjuvant (FCA), the rats were treated with Daphnetin (2.25 and 4.5mg/kg) for three weeks. We determined the change of secondary paw swelling and the arthritis scores of these tested rats. The severity of arthritis in the knee joints was evaluated by histological assessment of cartilage destruction. The levels of IL-1, TNF-alpha and MIF in the serum were measured by ELISA. Our results showed that Daphnetin significantly reduced paw swelling and decreased the arthritis scores. The pathological examination demonstrated that articular cartilage degeneration with synovial hyperplasia and inflammatory cells infiltration in AA rats were suppressed by Daphnetin. There was significant reduction in production of interleukin-1 (IL-1), tumor necrosis factor (TNF-alpha) and macrophage migration inhibitory factor (MIF) in serum of AA rats treated with Daphnetin except the low dose group (2.25mg/kg) on TNF-alpha.
CONCLUSIONS:
In conclusion, we demonstrates that Daphnetin is highly effective on preventing and suppressing the development and progression of adjuvant-induced arthritis and provides direct evidences that Daphnetin is one of the active principle of Zushima-Pian for treating rheumatoid arthritis.
Structure Identification:
Biochem Biophys Res Commun. 1999 Jul 14;260(3):682-5.
Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor.[Pubmed: 10403826 ]
Protein kinases play key roles in the control of cell proliferation, differentiation and metabolism.
METHODS AND RESULTS:
In this work, we studied the effect of coumarin and its derivatives, including Daphnetin, esculin, 2-OH-coumarin, 4-OH-coumarin and 7-OH-coumarin, on the activity of protein kinases. It was found that, in these compounds, only Daphnetin was a protein kinase inhibitor. This compound inhibited tyrosine-specific protein kinase, EGF receptor (IC(50) = 7.67 microM), and serine/threonine-specific protein kinases, including cAMP-dependent protein kinase (PKA) (IC(50) = 9.33 microM) and protein kinase C (PKC) (IC(50) = 25.01 microM) in vitro. The inhibition of EGF receptor tyrosine kinase by Daphnetin was competitive to ATP and non-competitive to the peptide substrate. The inhibition of EGF-induced tyrosine phosphorylation of EGF receptor by Daphnetin was not observed in human hepatocellular carcinoma HepG2 cells.
CONCLUSIONS:
The structural comparison of Daphnetin with coumarin and other coumarin derivatives suggests that the hydroxylation at C8 may be required for Daphnetin acting as a protein kinase inhibitor.
Rosavin

Catalog No: CFN99179
CAS No: 84954-92-7
Price: $68/20mg
Irisflorentin

Catalog No: CFN99788
CAS No: 41743-73-1
Price: $40/20mg
Astragaloside IV

Catalog No: CFN99171
CAS No: 84687-43-4
Price: $30/20mg
Alisol A

Catalog No: CFN92542
CAS No: 19885-10-0
Price: $80/20mg
Syringaresinol-di-O-glucoside

Catalog No: CFN90458
CAS No: 66791-77-3
Price: $138/20mg
Hispidulin

Catalog No: CFN99491
CAS No: 1447-88-7
Price: $218/20mg
Vicenin -1

Catalog No: CFN92030
CAS No: 35927-38-9
Price: $268/20mg
Momordicoside P

Catalog No: CFN92308
CAS No: 1011726-62-7
Price: $ / mg
Juglanin

Catalog No: CFN96238
CAS No: 5041-67-8
Price: $318/5mg
Myricitrin

Catalog No: CFN99840
CAS No: 17912-87-7
Price: $40/20mg
Tags: buy Daphnetin | Daphnetin supplier | purchase Daphnetin | Daphnetin cost | Daphnetin manufacturer | order Daphnetin | Daphnetin distributor